Exploring silver as a contrast agent for contrast-enhanced dual-energy X-ray breast imaging

British Journal of Radiology

Volumn 87, Issue 1041, 2014, Pages

  Karunamuni, R ^a   Tsourkas, A ^b   Maidment, A D A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; IODINE; SILVER;

ARTICLE; CONTRAST ENHANCED DUAL ENERGY X RAY BREAST IMAGING; CONTRAST ENHANCEMENT; IMAGING; IMAGING SYSTEM; INTERMETHOD COMPARISON; QUANTITATIVE ANALYSIS; SIGNAL DIFFERENCE TO NOISE RATIO; SIGNAL NOISE RATIO; THICKNESS; ALGORITHM; BREAST; BREAST TUMOR; COMPARATIVE STUDY; HUMAN; MAMMOGRAPHY; PROCEDURES; RADIATION SCATTERING; RADIOGRAPHY; THEORETICAL MODEL;

ALGORITHMS; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; HUMANS; IODINE; MAMMOGRAPHY; MODELS, THEORETICAL; SCATTERING, RADIATION; SIGNAL-TO-NOISE RATIO; SILVER;

EID: 84907546271     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20140081     Document Type: Article

References (39)

1. Jochelson MS, Dershaw DD, Sung JS, Heerdt AS, Thornton C, Moskowitz CS, et al. Bilateral contrast-enhanced dualenergy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 2013; 266: 743-51.
2. Froeling V, Diekmann F, Renz DM, Fallenberg EM, Steffen IG, Diekmann S, et al. Correlation of contrast agent kinetics between iodinated contrast-enhanced spectral tomosynthesis and gadolinium-enhanced MRI of breast lesions. Eur Radiol 2013; 23: 1528-36.
3. Dromain C, Thibault F, Diekmann F, Fallenberg EM, Jong RA, Koomen M, et al. Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study. Breast Cancer Res 2012; 14: R94. doi: 10.1186/bcr3210
4. Carton A-K, Ullberg C, Maidment AD. Optimization of a dual-energy contrastenhanced technique for a photon-counting digital breast tomosynthesis system: II. An experimental validation. Med Phys 2010; 37: 5908-13.
5. Carton AK, Ullberg C, Lindman K, Acciavatti R, Francke T, Maidment AD. Optimization of a dual-energy contrast-enhanced technique for a photon-counting digital breast tomosynthesis system: I. A theoretical model. Med Phys 2010; 37: 5896-907.
6. Carton AK, Gavenonis SC, Currivan JA, Conant EF, Schnall MD, Maidment AD. Dual-energy contrast-enhanced digital breast tomosynthesis - a feasibility study. Br J Radiol 2010; 83: 344-50. doi: 10.1259/bjr/80279516
7. Chen SC, Carton AK, Albert M, Conant EF, Schnall MD, Maidment ADA. Initial clinical experience with contrast-enhanced digital breast tomosynthesis. Acad Radiol 2008; 14: 229-38. doi: 10.1016/j.acra.2006.10.022
8. Lewin JM, Isaacs PK, Vance V, Larke FJ. Dualenergy contrast-enhanced digital subtraction mammography: feasibility. Radiology 2003; 229: 261-8. doi: 10.1148/radiol.2291021276
9. MedImaging.net. Contrast-enhanced spectral mammography offers dual-energy image acquisition [Cited 3 September 2013.] Available from: http://www.medimaging.net/radiography/articles/294737841/contrastenhanced-spectral-mammography-offers-dualenergy-image-acquisition.html
10. Molloi S. Spectral mammography using a photon counting detector provides a unique method for measurements of breast density. Amsterdam, Netherlands: Philips Healthcare; 2013.
11. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006; 79: 248-53. doi: 10.1259/bjr/13169882
12. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994; 45: 259-65.
13. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649-52.
14. Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol Res 2010; 62: 90-9. doi: 10.1016/j.phrs.2010.03.005
15. Han H, Davis ME. Single-antibody, targeted nanoparticle delivery of camptothecin. Mol Pharm 2013; 10: 2558-67. doi: 10.1021/mp300702x
16. Vlashi E, Kelderhouse LE, Sturgis JE, Low PS. Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors. ACS Nano 2013; 7: 8573-82. doi: 10.1021/nn402644g
17. Fang C, Shi B, Pei YY, Hong MH, Wu J, Chen HZ. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 2006; 27: 27-36. doi: 10.1016/j.ejps.2005.08.002
18. Cheng L, Yang K, Chen Q, Liu Z. Organic stealth nanoparticles for highly effective in vivo near-infrared photothermal therapy of cancer. ACS Nano 2012; 6: 5605-13. doi: 10.1021/nn301539m
19. Marra M, Salzano G, Leonetti C, Porru M, Franco R, Zappavigna S, et al. New selfassembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. Biotechnol Adv 2012; 30: 302-9. doi: 10.1016/j.biotechadv.2011.06.018
20. Karunamuni R, Maidment ADA. Search for novel contrast materials in dual-energy x-ray breast imaging using theoretical modeling of contrast-to-noise ratio. Phys Med Biol 2014; 59: 4311-24.
21. Nabikhan A, Kandasamy K, Raj A, Alikunhi NM. Synthesis of antimicrobial silver nanoparticles by callus and leaf extracts from saltmarsh plant, Sesuvium portulacastrum L. Colloids Surf B Biointerfaces 2010; 79: 488-93. doi: 10.1016/j.colsurfb.2010.05.018
22. Vaidyanathan R, Gopalram S, Kalishwaralal K, Deepak V, Pandian SR, Gurunathan S. Enhanced silver nanoparticle synthesis by optimization of nitrate reductase activity. Colloids Surf B Biointerfaces 2010; 75: 335-41. doi: 10.1016/j.colsurfb.2009.09.006
23. Silvert P, Duvauchelle N, Vijayakrishnan V, Elhsissen KT. Preparation of colloidal silver dispersions by the polyol process. J Mater Chem 1996; 6: 573-7.
24. Wiley B, Herricks T, Sun Y, Xia Y. Polyol synthesis of silver nanoparticles: use of chloride and oxygen to promote the formation of single-crystal, truncated cubes and tetrahedrons. Nano Lett 2004; 4: 1733-9.
25. Liu J, Hurt RH. Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ Sci Technol 2010; 44: 2169-75. doi: 10.1021/es9035557
26. Verma VC, Kharwar RN, Gange AC. Biosynthesis of antimicrobial silver nanoparticles by the endophytic fungus Aspergillus clavatus. Nanomedicine (Lond) 2010; 5: 33-40. doi: 10.2217/nnm.09.77
27. Musarrat J, Dwivedi S, Singh BR, Al- Khedhairy AA, Azam A, Naqvi A. Production of antimicrobial silver nanoparticles in water extracts of the fungus Amylomyces rouxii strain KSU-09. Bioresour Technol 2010; 101: 8772-6. doi: 10.1016/j.biortech.2010.06.065
28. Mehra S, Christoforo MG, Peumans P, Salleo A. Solution processed zinc oxide nanopyramid/silver nanowire transparent network films with highly tunable light scattering properties. Nanoscale 2013; 5: 4400-3.
29. Kahraman M, Sur I, Mustafa C. Label-free detection of proteins from self-assembled protein-silver nanoparticle structures using surface-enhanced Raman scattering. Anal Chem 2010; 82: 7596-602. doi: 10.1021/ac101720s
30. Chen LQ, Xiao SJ, Peng L, Wu T, Ling J, Li YF, et al. Aptamer-based silver nanoparticles used for intracellular protein imaging and single nanoparticle spectral analysis. J Phys Chem B 2010; 114: 3655-9. doi: 10.1021/jp9104618
31. Kumar A, Vemula PK, Ajayan PM, John G. Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. Nat Mater 2008; 7: 236-41. doi: 10.1038/nmat2099
32. McFarland AD, Van Duyne RP. Single silver nanoparticles as real-time optical sensors with zeptomole sensitivity. Nano Lett 2003; 3: 1057-62.
33. Dance DR, Skinner CL, Young KC, Beckett JR, Kotre CJ. Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol. Phys Med Biol 2000; 45: 3225-40.
34. Dance DR. Monte Carlo calculation of conversion factors for the estimation of mean glandular breast dose. Phys Med Biol 1990; 35: 1211-19.
35. Boone JM, Fewell TR, Jennings RJ. Molybdenum, rhodium, and tungsten anode spectral models using interpolating polynomials with application to mammography. Med Phys 1997; 24: 1863-74.
36. Marshall NW, Monnin P, Bosmans H, Bochud FO, Verdun FR. Image quality assessment in digital mammography: part I. Technical characterization of the systems. Phys Med Biol 2011; 56: 4201-20.
37. Brettle DS, Cowen AR. Dual-energy digital mammography utilizing stimulated phosphor computed radiography. Phys Med Biol 1994; 39: 1989-2004.
38. Bliznakova K, Kolitsi Z, Pallikarakis N. Dual-energy mammography: simulation studies. Phys Med Biol 2006; 51: 4497-515. doi: 10.1088/0031-9155/51/18/004
39. Karunamuni R, Zaki AA, Popov AV, Delikatny EJ, Gavenonis S, Tsourkas A, et al. An examination of silver as a radiographic contrast agent in dual-energy breast X-ray imaging. In: IWDM 12 Proceedings of the 11th International Conference on Breast Imaging. Berlin, Germany: Springer-Verlag. pp.418-25.